T\u00e1 d\u01b0\u1ee3c v\u1eeba \u0111\u1ee7.<\/li>\n<\/ul>\nD\u1ea1ng b\u00e0o ch\u1ebf : Vi\u00ean nang c\u1ee9ng<\/p>\n
Tr\u00ecnh b\u00e0y<\/h3>\n
S\u0110K: 730110017023<\/p>\n
Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 10 v\u1ec9 x 6 vi\u00ean<\/p>\n
Xu\u1ea5t x\u1ee9: Th\u1ee5y \u0110i\u1ec3n<\/p>\n
T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Calquence 100mg<\/h2>\nC\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n
Bruton tyrosine kinase l\u00e0 th\u00e0nh ph\u1ea7n g\u1ea7n c\u1ee7a con \u0111\u01b0\u1eddng truy\u1ec1n t\u00edn hi\u1ec7u th\u1ee5 th\u1ec3 t\u1ebf b\u00e0o B v\u00e0 l\u00e0 m\u1ee5c ti\u00eau \u0111i\u1ec1u tr\u1ecb cho nhi\u1ec1u lo\u1ea1i b\u1ec7nh \u00e1c t\u00ednh t\u1ebf b\u00e0o B. Acalabrutinib t\u1ea1o li\u00ean k\u1ebft c\u1ed9ng h\u00f3a tr\u1ecb v\u1edbi Cys481 trong t\u00fai li\u00ean k\u1ebft ATP d\u1eabn \u0111\u1ebfn \u1ee9c ch\u1ebf bruton tyrosine kinase kh\u00f4ng h\u1ed3i ph\u1ee5c.<\/p>\n
Khi Bruton tyrosine kinase b\u1ecb b\u1ea5t ho\u1ea1t, t\u00edn hi\u1ec7u downstream c\u1ee7a B\u2011cell receptor gi\u1ea3m m\u1ea1nh, th\u1ec3 hi\u1ec7n qua s\u1ef1 gi\u1ea3m phosphoryl h\u00f3a PLC\u03b32, ERK v\u00e0 I\u03baB, t\u1eeb \u0111\u00f3 k\u00ecm h\u00e3m con \u0111\u01b0\u1eddng NF\u2011\u03baB v\u00e0 AKT, l\u00e0m gi\u1ea3m t\u0103ng sinh, di c\u01b0 v\u00e0 kh\u1ea3 n\u0103ng t\u1ed3n t\u1ea1i c\u1ee7a t\u1ebf b\u00e0o B \u00e1c t\u00ednh. Nh\u1edd \u0111\u00f3 ccalabrutinib \u1ee9c ch\u1ebf m\u1ea1nh s\u1ef1 h\u00ecnh th\u00e0nh kh\u1ed1i u v\u00e0 c\u00f3 th\u1ec3 k\u00e9o d\u00e0i th\u1eddi gian s\u1ed1ng s\u00f3t c\u1ee7a b\u1ec7nh nh\u00e2n.<\/p>\n
Kh\u00f4ng gi\u1ed1ng nh\u01b0 ibrutinib, acalabrutinib c\u00f3 t\u00ednh ch\u1ecdn l\u1ecdc cao h\u01a1n v\u00e0 kh\u00f4ng \u1ee9c ch\u1ebf c\u00e1c kinase kh\u00e1c, bao g\u1ed3m EGFR, TEC ho\u1eb7c ITK. Nh\u1edd \u0111\u00f3 acalabrutinib \u00edt g\u00e2y ra t\u00e1c d\u1ee5ng kh\u00f4ng mong mu\u1ed1n h\u01a1n ibrutinib.<\/p>\n
\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h3>\nH\u1ea5p thu<\/h4>\n
Sinh kh\u1ea3 d\u1ee5ng kho\u1ea3ng 25-40% sau khi u\u1ed1ng.<\/p>\n
Ph\u00e2n b\u1ed1<\/h4>\n
Th\u1ec3 t\u00edch ph\u00e2n b\u1ed1 kho\u1ea3ng 101L, li\u00ean k\u1ebft ch\u1eb7t ch\u1ebd v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng<\/p>\n
Chuy\u1ec3n h\u00f3a<\/h4>\n
Acalabrutinib \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a ch\u1ee7 y\u1ebfu b\u1edfi enzyme CYP3A4 (oxi h\u00f3a v\u00f2ng pyrrolidin), k\u00e8m theo li\u00ean k\u1ebft v\u1edbi glutathione v\u00e0 th\u1ee7y ph\u00e2n amid, t\u1ea1o ch\u1ea5t chuy\u1ec3n h\u00f3a ho\u1ea1t \u0111\u1ed9ng ACP\u20115862.<\/p>\n
Th\u1ea3i tr\u1eeb<\/h4>\n
Th\u1eddi gian b\u00e1n th\u1ea3i kho\u1ea3ng 1-2 gi\u1edd.<\/p>\n
Calquence 100mg \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n
Calquence 100mg Acalabrutinib<\/strong> \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong :<\/p>\n\n- U lympho t\u1ebf b\u00e0o v\u1ecf (MCL): \u0111i\u1ec1u tr\u1ecb cho ng\u01b0\u1eddi l\u1edbn \u0111\u00e3 nh\u1eadn \u00edt nh\u1ea5t m\u1ed9t li\u1ec7u ph\u00e1p tr\u01b0\u1edbc \u0111\u00f3 nh\u01b0ng b\u1ec7nh c\u00f2n t\u00e1i ph\u00e1t ho\u1eb7c kh\u00e1ng tr\u1ecb.<\/li>\n
- B\u1ec7nh b\u1ea1ch c\u1ea7u lympho m\u1ea1n t\u00ednh (CLL) ho\u1eb7c u lympho nh\u1ecf (SLL): \u0111i\u1ec1u tr\u1ecb cho ng\u01b0\u1eddi l\u1edbn, c\u1ea3 tr\u01b0\u1eddng h\u1ee3p \u0111\u00e3 \u0111i\u1ec1u tr\u1ecb tr\u01b0\u1edbc \u0111\u00f3 ho\u1eb7c \u0111i\u1ec1u tr\u1ecb \u0111\u1ea7u tay (\u0111\u01a1n \u0111\u1ed9c ho\u1eb7c ph\u1ed1i h\u1ee3p v\u1edbi obinutuzumab).<\/li>\n<\/ul>\n
Calquence 100mg \u0111i\u1ec1u tr\u1ecb u lympho t\u1ebf b\u00e0o v\u1ecf<\/figcaption><\/figure>\nLi\u1ec1u d\u00f9ng c\u1ee7a thu\u1ed1c Calquence 100mg<\/h2>\n\n- 1\u202fvi\u00ean\/l\u1ea7n, 2\u202fl\u1ea7n\/ng\u00e0y<\/li>\n
- Kho\u1ea3ng c\u00e1ch gi\u1eefa c\u00e1c li\u1ec1u:\u202f12\u202fgi\u1edd<\/li>\n
- \u0110i\u1ec1u ch\u1ec9nh li\u1ec1u theo ch\u1ec9 \u0111\u1ecbnh c\u1ee7a b\u00e1c s\u0129 d\u1ef1a tr\u00ean t\u00ecnh tr\u1ea1ng b\u1ec7nh nh\u00e2n<\/li>\n<\/ul>\n
C\u00e1ch d\u00f9ng c\u1ee7a thu\u1ed1c Calquence 100mg<\/h2>\n\n- Nu\u1ed1t nguy\u00ean vi\u00ean, kh\u00f4ng b\u1ebb, nhai, nghi\u1ec1n hay chia nh\u1ecf.<\/li>\n
- C\u00f3 th\u1ec3 u\u1ed1ng c\u00f9ng ho\u1eb7c kh\u00f4ng c\u00f9ng th\u1ee9c \u0103n theo h\u01b0\u1edbng d\u1eabn c\u1ee7a b\u00e1c s\u0129.<\/li>\n
- U\u1ed1ng \u0111\u1ee7 li\u1ec1u v\u00e0 \u0111\u00fang gi\u1edd \u0111\u1ec3 duy tr\u00ec n\u1ed3ng \u0111\u1ed9 thu\u1ed1c \u1ed5n \u0111\u1ecbnh trong m\u00e1u.<\/li>\n<\/ul>\n
Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Calquence 100mg trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/h2>\n\n- Kh\u00f4ng d\u00f9ng Calquence 100mg cho ng\u01b0\u1eddi c\u00f3 m\u1eabn c\u1ea3m v\u1edbi b\u1ea5t k\u1ef3 th\u00e0nh ph\u1ea7n n\u00e0o c\u1ee7a thu\u1ed1c.<\/li>\n
- Tr\u1ebb d\u01b0\u1edbi 18 tu\u1ed5i.<\/li>\n<\/ul>\n